First Tracks Biotherapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -207 | |||
EBITDA | -34,730 | -52,686 | -45,297 | -50,674 |
EBIT | -34,937 | -52,811 | -45,898 | -51,280 |
Net Income | -33,374 | -50,484 | -42,445 | -47,196 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -31,943 | -32,578 | -38,676 | -45,041 |
Cash | 168,018 | 248,469 | 385,373 | |
Basic Shares | 35,390 | 34,748 | 34,748 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 |
|---|---|---|
Revenue | $0 | $0 |
Gross Profit | -152,345 | |
EBITDA | -178,704 | -116,085 |
EBIT | -181,101 | -118,461 |
Net Income | -163,705 | -106,150 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -126,164 | -93,811 |
Cash | 123,080 | 35,965 |
Basic Shares | 34,748 | 34,748 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.95 |
2026-03-31 | -$1.44 |